Cure One has obtained Full Membership within the European INNODIA network
INNODIA is a leading European collaborative initiative focused on innovation in type 1 diabetes research and is currently actively working on the establishment of a clinical research site.
In addition, Cure One has already been fulfilling the role of INNODIA Immune Hub, where blood samples from people with type 1 diabetes, their family members, and clinical trial participants are processed, monitored, and stored. These activities support research efforts in the Netherlands, Belgium, Scandinavia, Slovenia, and Germany.